PDL Biopharma
PDLI
#8128
Rank
โ‚น26.25 B
Marketcap
โ‚น229.82
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -โ‚น9.63 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are โ‚น80.61 Million. In 2019 the company made an earning of -โ‚น5.81 Billion a decrease over its 2018 earnings that were of -โ‚น4.08 Billion.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-โ‚น9.63 Billion65.86%
2019-โ‚น5.81 Billion42.43%
2018-โ‚น4.08 Billion-121.38%
2017โ‚น19.05 B60.41%
2016โ‚น11.87 B-77.09%
2015โ‚น51.84 B3.09%
2014โ‚น50.28 B26.65%
2013โ‚น39.70 B19.82%
2012โ‚น33.14 B3.68%
2011โ‚น31.96 B77.17%
2010โ‚น18.04 B-35.29%
2009โ‚น27.88 B23.45%
2008โ‚น22.58 B-1751.42%
2007-โ‚น1.37 Billion-88.56%
2006-โ‚น11.96 Billion93.73%
2005-โ‚น6.17 Billion13.63%
2004-โ‚น5.43 Billion32.12%
2003-โ‚น4.11 Billion87.44%
2002-โ‚น2.2 Billion-302.45%
2001โ‚น1.08 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น2.394 T-19,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น835.18 B-6,923.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.15 Billion-17.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น2.57 Billion-79.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-โ‚น14.47 Billion 18.19%๐Ÿ‡บ๐Ÿ‡ธ USA